Merck & Co., Inc. (MRK)

NYSE: MRK · Delayed Price · USD
0.06 (0.07%)
At close: Jan 14, 2022 4:02 PM
0.02 (0.02%)
After-hours:Jan 14, 2022 7:57 PM EST

Total Valuation

Merck & Co. has a market cap or net worth of $205.56 billion. The enterprise value is $221.99 billion.

Market Cap205.56B
Enterprise Value221.99B

Important Dates

The latest earnings date was Thursday, October 28, 2021 before market open.

Last Earnings DateOct 28, 2021
Ex-Dividend DateDec 14, 2021

Share Statistics

Merck & Co. has 2.53 billion shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding2.53B
Shares Change (YoY)+0.08%
Shares Change (QoQ)-0.03%
Owned by Insiders (%)0.07%
Owned by Institutions (%)74.54%

Valuation Ratios

The trailing PE ratio is 28.72 and the forward PE ratio is 10.10. Merck & Co.'s PEG ratio is 1.16.

PE Ratio28.72
Forward PE10.10
PS Ratio4.18
PB Ratio5.74
P/FCF Ratio24.68
PEG Ratio1.16
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.42, with a EV/FCF ratio of 26.65.

EV / Earnings30.84
EV / Sales4.52
EV / EBITDA18.42
EV / EBIT25.31
EV / FCF26.65

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.74.

Current Ratio1.31
Quick Ratio0.78
Debt / Equity0.74
Debt / EBITDA2.19
Debt / FCF3.17

Financial Efficiency

Return on equity (ROE) is 23.70%, which is very high. The company has a high ROIC of 16.10%.

Return on Equity (ROE)23.70%
Return on Assets (ROA)7.90%
Return on Capital (ROIC)16.10%
Revenue Per Employee$673,301
Profits Per Employee$98,589
Employee Count73,000
Asset Turnover0.54
Inventory Turnover2.69


In the past 12 months, Merck & Co. has paid $1.57 billion in taxes.

Income Tax1.57B
Effective Tax Rate17.93%

Stock Price Statistics

The stock price has decreased by -2.60% in the last 52 weeks. The beta is 0.50, so Merck & Co.'s price volatility has been lower than the market average.

Beta (1Y)0.50
52-Week Price Change-2.60%
50-Day Moving Average76.18
200-Day Moving Average77.14
Average Volume (30 Days)13,782,400

Short Selling Information

Short Interest23.16M
Short % of Shares Out0.92%
Short % of Float0.92%
Short Ratio (days to cover)1.66

Income Statement

In the last 12 months, Merck & Co. had revenue of $49.15 billion and earned 7.20 billion in profits. Earnings per share was $2.83.

Gross Profit33.39B
Operating Income7.20B
Pretax Income8.77B
Net Income7.20B
Earnings Per Share (EPS)$2.83
Full Income Statement

Balance Sheet

The company has $10.02 billion in cash and $26.44 billion in debt, giving a net cash position of -$16.43 billion or -$6.50 per share.

Cash & Cash Equivalents10.02B
Total Debt26.44B
Net Cash-16.43B
Net Cash Per Share-$6.50
Book Value35.79B
Book Value Per Share14.17
Working Capital7.33B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $13.08 billion and capital expenditures -$4.75 billion, giving a free cash flow of $8.33 billion.

Operating Cash Flow13.08B
Capital Expenditures-4.75B
Free Cash Flow8.33B
FCF Per Share$3.30
Full Cash Flow Statement


Gross margin is 67.94%, with operating and profit margins of 14.64% and 14.64%.

Gross Margin67.94%
Operating Margin14.64%
Pretax Margin17.84%
Profit Margin14.64%
EBITDA Margin24.52%
EBIT Margin17.84%
FCF Margin16.95%

Dividends & Yields

This stock pays an annual dividend of $2.61, which amounts to a dividend yield of 3.21%.

Dividend Per Share$2.61
Dividend Yield3.21%
Earnings Yield3.50%
FCF Yield4.05%
Dividend Growth (YoY)6.56%
Payout Ratio91.20%

Stock Splits

The last stock split was on June 3, 2021. It was a forward split with a ratio of 1048:1000.

Last Split DateJun 3, 2021
Split TypeForward
Split Ratio1048:1000